THE EFFECT OF DPP4 INHIBITOR ON RENAL ANEMIA IN HEMODIALYSIS PATIENTS

被引：0
作者：
Aono, Masaki [1 ]
Sato, Yuzuru [1 ]
机构：
[1] Sato Junkanki Hosp, Internal Med, Matsuyama, Ehime, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv182.4
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP656
引用
收藏
页数：1
相关论文
共 50 条
[41]   The Effect of DPP4 Inhibitor on Glycemic Variability in Patients with Type 2 Diabetes treated with twice-daily Premixed Human Insulin [J].
Tan, Florence Hui Sieng ;
Tong, Chin Voon ;
Lau, Bik Kui ;
Kuan, Yueh Chien ;
Loh, Huai Heng ;
Pillai, Saravanan A. L. Vengadesa ;
Tiong, Xun Ting .
JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2021, 36 (02) :167-171
[42]   DPP4 Activity, Hyperinsulinemia, and Atherosclerosis [J].
Love, Kaitlin M. ;
Liu, Zhenqi .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (06) :1553-1565
[43]   DPP4 inhibitors and the matters of metaflammation! [J].
Magoon, Rohan .
MEDICAL HYPOTHESES, 2025, 197
[44]   Implications of the prolonged dissociation rate of saxagliptin, a highly potent and selective DPP4 inhibitor, on plasma DPP measurements [J].
Wang, Aiying ;
Dorso, Charles ;
Kopcho, Lisa ;
Marcinkeviciene, Jovita ;
Kirby, Mark S. .
DIABETES, 2008, 57 :A576-A577
[45]   Glucometabolic control of once-weekly dulaglutide switched from DPP4 inhibitor versus daily empagliflozin add-on in patients with type 2 diabetes inadequately controlled with metformin, sulfonylurea, and DPP4 inhibitor: A randomised trial [J].
Lee, Eun Young ;
Cho, Jae-Hyoung ;
Lee, Woo Je ;
Kim, Nam Hoon ;
Kim, Jae Hyeon ;
Lee, Byung-Wan .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 203
[46]   Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model [J].
Shrestha, Neha ;
Araujo, Francisca ;
Shahbazi, Mohammad-Ali ;
Makila, Ermei ;
Gomes, Maria Joao ;
Airavaara, Mikko ;
Kauppinen, Esko I. ;
Raula, Janne ;
Salonen, Jarno ;
Hirvonen, Jouni ;
Sarmento, Bruno ;
Santos, Helder A. .
JOURNAL OF CONTROLLED RELEASE, 2016, 232 :113-119
[47]   The effect of a DPP4 inhibitor on morphometry of pancreatic beta cells after lactation on female wistar rats. [J].
Suen, Vivian ;
Ribas-Filho, Durval ;
Cersosimo, Eugenio ;
Martins, Alex ;
Marchini, Julio Sergio ;
Azoubel, Reinaldo .
FASEB JOURNAL, 2013, 27
[48]   Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway [J].
Sato, Youichi ;
Koshioka, Sakura ;
Kirino, Yasushi ;
Kamimoto, Takayuki ;
Kawazoe, Kazuyoshi ;
Abe, Shinji ;
Minakuchi, Kazuo ;
Nakahori, Yutaka .
LIFE SCIENCES, 2011, 88 (1-2) :43-49
[49]   Preconception SGLT2 or DPP4 inhibitor use and adverse pregnancy outcomes [J].
Ray, Joel G. ;
Harel, Ziv ;
Gilbert, Richard E. ;
Wald, Ron ;
Berger, Howard ;
Park, Alison L. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 205
[50]   DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility [J].
Wang, Xinxin ;
Gu, Haitao ;
Li, Kaichun ;
Lin, Jiayun ;
Zhu, Yiming ;
Deng, Wensheng .
LIFE SCIENCES, 2021, 284
12345